p53 but not erbB-2 expression is associated with rapid tumor proliferation in urinary bladder cancer
- 1 December 1994
- journal article
- Published by Elsevier in Human Pathology
- Vol. 25 (12) , 1346-1351
- https://doi.org/10.1016/0046-8177(94)90096-5
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- p53 anderbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancerVirchows Archiv, 1993
- Molecular Genetic Alterations of Chromosome 17 and p53 Nuclear Overexpression in Human Bladder CancerDiagnostic Molecular Pathology, 1993
- Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease ProgressionJNCI Journal of the National Cancer Institute, 1993
- Association of C‐erbB‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancerInternational Journal of Cancer, 1991
- Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformationPublished by Elsevier ,1991
- Tumor suppressor p53: analysis of wild-type and mutant p53 complexes.Molecular and Cellular Biology, 1991
- Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53Science, 1990
- Increased expression of mutant forms of p53 oncogene in primary lung cancerThe Lancet, 1990
- Structural basis for epidermal growth factor receptor functionProgress in Growth Factor Research, 1989
- Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Molecular and Cellular Biology, 1988